Curriculum Vitae - Mahmoud Kandeel (Member)

• Master from department of Pharmacology and therapeutics, faculty of Veterinary medicine, Tanta University, Egypt. In 8/2002. Title: The effect of diclazuril and semduramicin as prophylactic or therapeutic treatments on broilers infected with E. tenella
• Ph.D. from Department of Biomolecular science, Graduate school of engineering, Gifu University, Japan in 9/2009. Title: Pharmacogenomic and biomolecular investigation of target nucleic acids metabolizing enzymes for development of new antimicrobial drugs.
• 2000-2002   Demonstrator, Department of Pharmacology and Therapeutics, College of Veterinary Medicine, Kafrelsheikh University, Egypt
• 2002-2005  Assistant lecturer, Department of Pharmacology and Therapeutics, College of Veterinary Medicine, Kafrelsheikh University, Egypt
• 2005-2009   PhD student at Gifu university Japan
• 2009-   Lecturer, Department of Pharmacology and Therapeutics, College of Veterinary Medicine, Kafrelsheikh University, Egypt
• 2011-2013  Research associate, Gifu university, Japan
• 2013-now   Assistant professor. Department of Biomedical Sciences, College of Veterinary Medicine, King Faisal University, Saudi Arabia.
• 2016-2021  Associate professor, Department of Pharmacology and Therapeutics, College of Veterinary Medicine, Kafrelsheikh University, Egypt
• 2021-now  Professor, Department of Pharmacology and Therapeutics, College of Veterinary Medicine, Kafrelsheikh University, Egypt
• 2023-now Associate professor. Department of Biomedical Sciences, College of Veterinary Medicine, King Faisal University, Saudi Arabia.
• Google scholar    http://scholar.google.com/citations?user=cFgdD-4AAAAJ&hl=en
• Researcher ID     http://www.researcherid.com/rid/G-3636-2016
• Scopus                 https://www.scopus.com/authid/detail.uri?authorId=22937486100
• ORCID                http://orcid.org/0000-0003-3668-5147
• Researchgate      https://www.researchgate.net/profile/Mahmoud_Kandeel2
• Facebook            https://www.facebook.com/mahmoud.kandeel.7?ref=tn_tnmn
• Live DNA             http://livedna.net/?dna=20.1479
• MEDT (journal)  http://www.medt.com.es/editors.php

• 2000-2005: Practical course of experimental pharmacology and dispensing for undergraduate students,  Faculty of Veterinary Medicine, Tanta University, Egypt
• 2006-2009: Teaching and research of molecular biochemistry, biomolecular science and material engineering in Gifu University, Graduate School of Engineering, Department of Biomolecular science
• 2009-2011: Teaching Pharmacology courses for undergraduate, diploma and master students in department of Pharmacology and Therapeutics, Faculty of Veterinary Medicine, Kafrelshiekh University, Egypt
• 2011-2013: Research associate in the United graduate school of drug discovery and medical information sciences.
• 2013-Present: Teaching Pharmacology courses for undergraduate and master students in department of Biomedical Sciences, College of Veterinary Medicine, King Faisal University, Saudi Arabia

• 2008: EJISST award and distinction medal from the Egyptian Culture Office, Tokyo, Japan.
• 2009: Best published figure and used as the cover of Parasitology journal(Cambridge univerity press) Parasitology journal, UK
• 2009: Kafrelsheikh University publication awards 2009 (1 article)Kafrelsheikh University-Egypt
• 2011: Best personal website design - Kafrelsheikh University-Egypt
• 2011: Kafrelsheikh University publication awards 2011 (1 article) Kafrelsheikh University-Egypt
• 2012: Kafrelsheikh University publication awards 2012 (3 articles)Kafrelsheikh University-Egypt
• 2013: Who's Who publications Award, USA The Marquis Who`s Who publications Board, USA
• 2013: Best published figure and published as the cover of ActaVirologica (Journal)
• 2014: Kafrelsheikh University publication awards 2014 (7 articles)  Kafrelsheikh University-Egypt
• 2017: The best initiative award, King Faisal University strategic plan         
• 2018: Kafrelsheikh University publication awards 2018 (4 articles)  Kafrelsheikh University-Egypt
• 2019: Kafrelsheikh University publication awards 2019 (5 articles)  Kafrelsheikh University-Egypt
• 2019: The Excellent Veterinary Researcher in Saudi Arabia Amarai Inc.
• 2020: The best initiative award in scientific research, King Faisal University
• 2021: The best reviewer award Elsevier- Life Sciences (Journal)
• 2022: Excellence award,  The best publication award,  https://hmg.com/pages/rc.aspx, Dr. SulaimanAlhabib medical journal

2021-2023 selected publications on Camel research (1-24)

• Ahmed A, Mahmoud K.2023. MVA-based vaccine efficacies on the immune response and seroprevalence of MERS-CoV: A systematic review. The Journal of Camel Practice and Research 30:9-17.
• Al-Hizab FA, Kandeel M.2022. The Camels, Humans and Bovines Haemoglobin: In Silico and Molecular Dynamics Perspective and Binding Potency with Haeme. The Journal of Camel Practice and Research 29:305-311.
• Alkattan A, Alkohaidan M, Afzal S, Manap ASA, Kandeel M.2023. Camel Milk and it’s Applications in Treatment of Diabetes: Systematic Review and Meta-Analysis. The Journal of Camel Practice and Research 30:257-265.
• Al-Kubati AA, Hussen J, Kandeel M, Al-Mubarak AI, Hemida MG.2021. Recent advances on the bovine viral diarrhea virus molecular pathogenesis, immune response, and vaccines development. Frontiers in veterinary science 8:665128.
• Al-Kubati AA, Kandeel M, Hussen J, Hemida MG, Al-Mubarak AI.2023. Immunoinformatic prediction of the pathogenicity of bovine viral diarrhea virus genotypes: implications for viral virulence determinants, designing novel diagnostic assays and vaccines development. Frontiers in Veterinary Science 10.
• Al-Mubarak AI, Al-Kubati AA, Hussen J, Kandeel M, Hemida MG.2022. Modern Advances on the Diagnosis of Bovine Viral Diarrhoea Virus In Camelids. The Journal of Camel Practice and Research 29:49-60.
• Al-Mubarak AI, Hussen J, Kandeel M, Al-Kubati AA, Falemban B, Skeikh A, Hemida MG.2022. Risk-associated factors associated with the bovine viral diarrhea virus in dromedary camels, sheep, and goats in abattoir surveillance and semi-closed herd system. Veterinary World 15:1924-1931.
• El-Bahr SM, Kandeel M, Albokhadaim I, Al-Nazawi M, Ahmed H.2022. Reverse Diagnostic Workflow to Shortlist Mers-Cov Spike Antigenic Epitopes in Dromedary Camels. Journal of Camel Practice and Research 29:117-125.
• El-Bahr SM, Kandeel M, Albokhadaim I, Al-Nazawi M, Ahmed H.2022. MERS-CoV in Dromedary Camels: Sequence-Based Comparison of Antigenicity and Pathogenicity of Structural and Non-Structural Proteins. Journal of Camel Practice and Research 29:105-110.
• Hussen J, Kandeel M, Shawaf T, Al-Mubarak AI, Al-Humam NA, Almathen F.2021. Immunomodulatory effects of the cyclooxygenase inhibitor lornoxicam on phenotype and function of camel blood leukocytes. Animals 11:2023.
• Kandeel M, Alhumam, M.N., Al-Taher, A.2021. Bioinformatics of thymidine metabolism in Trypanosoma evansi: exploring nucleoside deoxyribosyltransferase (NDRT) as a drug target. Tropical Biomedicine 38:311-317.
• Kandeel M.2022. Meta-analysis of seroprevalence and zoonotic infections of Middle East respiratory syndrome coronavirus (MERS-CoV): A one-health perspective. One Health 15:100436.
• Kandeel M.2022. Antidiabetic, Anticolitis and Anticancer Activity in Camel Milk: A Systematic Analysis. Journal of Camel Practice and Research 29:365-372.
• Kandeel M.2023. An overview of the recent progress in Middle East Respiratory Syndrome Coronavirus (MERS-CoV) drug discovery. Expert Opinion on Drug Discovery 18:385-400.
• Kandeel M, Albusadah K, Alaydaa SH, Albokhadaim I, Alhojaily S, Marzok M.2021. Insulin from human, camel and farm animals: comparative bioinformatics and molecular dynamics studies. Pakistan Veterinary Journal:21-193.
• Kandeel M, Al-Mubarak AI.2022. Camel viral diseases: Current diagnostic, therapeutic, and preventive strategies. Frontiers in Veterinary Science:1218.
• Kandeel M, Almubarak AI, Hussen J, El-Deeb W, Venugopala KN.2021. Pharmacokinetic, Clinical, and Myeloid Marker Responses to Acepromazine Sedation in Arabian Camels. Frontiers in Veterinary Science 8:725841.
• Kandeel M, Al-Taher A, Venugopala KN, Marzok M, Morsy M, Nagaraja S.2022. Camel enzymes and proteins: a growing resource for functional evolution and environmental adaptation. Frontiers in Veterinary Science:1036.
• Kandeel M, El Sebaei MG, Ba Abdullah MM, Al-Sultan SI, Abdel-Raheem SM.2022. Bioinformatics and Molecular Modeling of the Camel Insulin Receptor. The Journal of Camel Practice and Research 29:7-15.
• Kandeel M, Morsy MA, Abd El-Lateef HM, Marzok M, El-Beltagi HS, Al Khodair KM, Albokhadaim I, Venugopala KN.2023. Safety and immunogenicity of the ChAdOx1, MVA-MERS-S, and GLS-5300 DNA MERS-CoV vaccines. International Immunopharmacology 118:109998.
• Kandeel M, Morsy MA, El-lateef A, Hany M, Marzok M, El-Beltagi H, Alkhodair K, Albokhadaim I, Venugopala KN.2023. A Century of" Camel Research": A Bibliometric Analysis. Frontiers in Veterinary Science 10:700.
• Kandeel M, Suganuma K.2022. The broad-spectrum antitrypanosomal inhibitory efficiency of the antimetabolite/anticancer drug raltitrexed. Processes 10:2158.
• M Kandeel AA-T.2021. Molecular Landscapes of Deoxyuridine 5'-Triphosphatase (dUTPase) as a Drug Target against Camel Trypanosoma evansi. Pakistan Veterinary Journal 41:235-241.
• Mahmoud Kandeel WE-D, Mahmoud Fayez, Ibrahim Ghoneim.2021. PHARMACOKINETICS OF THE LONG-ACTING CEFTIOFUR CRYSTALLINE- FREE ACID IN ARABIAN SHE-CAMELS (Camelus Dromedarius). Slov Vet Res 58:95 –101.

2021:   Patent application no. 32087.18(attorney) USPTO no 199342/17

            United States Patent Office (USPTO)

            Title : MERS-CoV INHIBITOR PEPTIDES

            Inventors: Mahmoud Kandeel, Mohammed Al-Nazawi, Abdulla Al-Taher, Hyung-Jo Kwon

            Status: Published

            Publication date: 2022-4-13

            Patent no. US-10975126-B1

2022:   Patent application no. 32087.44 (attorney) USPTO no 17/682107

            United States Patent Office (USPTO)

            Title: TREATMENT OF FUNGAL INFECTIONS USING DABIGATRAN ETEXILATE

            Inventors:  Mahmoud Kandeel, Abdulla Al-Taher, NaserAlhumam

            Status: Published

            Publication date: 2022-9-20

            Patent number: US-11446286-B1

2022:   Patent application no. 32087.34 (attorney) USPTO no 17/410,172

            United States Patent Office (USPTO)

            Title : ANTI-SARS-COV-2 FUSION PEPTIDES

            Inventors: Mahmoud Kandeel, Mizuki Yamamoto, JinGohda, Jun-ichiro Inoue, Yasushi

                              Kawaguchi, Hyung-Joo Kwon, Abdulla Al-Taher

            Status: Published

            Publication date: 2022-10-25

            Patent no. US-11479582-B2

2022:   Patent application no. 32087.20 (attorney) USPTO no 17/665553

            United States Patent Office (USPTO)

            Title: Method for treating inflammation

            Inventors: Mahmoud Kandeel and ShadiBurayk

            Status: Published

            Publication date: 2022-10-25

            Patent number: US-11478464-B1

2023:   Patent application no. 32087 60S (attorney) USPTO no

            United States Patent Office (USPTO) patent

            Title : Fusion peptide inhibitors of human coronavirus 229E

            Inventors: Mahmoud Kandeel, Abdulla Almubarak

            Status: Published

            Patent number: US-11707504-B1

2023:   Patent application no. 33102.24 (attorney)

            United States Patent Office (USPTO) patent

            Title: Broad-spectrum antitrypanosomal compounds

             Inventors: Mahmoud Kandeel

             Status: Published

             Patent number: US-11801249-B1

2023:   Patent application no. 33102.88 (attorney)

            United States Patent Office (USPTO) patent

            Title : Method of Treating Trypanosomiasis (Raltitrexed)

            Inventors: Mahmoud Kandeel

            Status: Published

            Publication date: 2023-10-31

            Patent number: US-11801247-B1

2023:   Patent application no. 33102.88 (attorney)

            United States Patent Office (USPTO) patent

            Title: Method of Treating Trypanosomiasis (Trypanocidal natural citrousflavonone glycoside)

            Inventors: Mahmoud Kandeel

            Status: Published

            Publication date: 2022-10-25

            Patent number: US-11806358-B1

2023:   Patent application no. 33102_34S (attorney)

            United States Patent Office (USPTO) patent

            Title: Novel Cyclooxygenase Inhibitors

            Inventors: Mahmoud Kandeel, Shady Burayk

            Status: Published

            Publication Date: 2022-10-25

            Patent number: US- 11786535-B1

2024:   Patent application no. 32087 60S (attorney) USPTO no

            United States Patent Office (USPTO) patent

            Title: Fusion peptide inhibitors of human coronavirus 229E

            Inventors: Mahmoud Kandeel

            Status: Published

            Publication date: 2024-1-9

            Patent number: US-11866461-B1